Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial von Delmas, P.D, Genant, H.K, Crans, G.G, Stock, J.L, Wong, M, Siris, E, Adachi, J.D

Volltext

A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease von SALLOWAY, S, SPERLING, R, CRANS, G, LIANG, E, QUINN, G, BAIRU, M, PASTRAK, A, CEDARBAUM, J. M, KEREN, R, PORSTEINSSON, A. P, VAN DYCK, C. H, TARIOT, P. N, GILMAN, S, ARNOLD, D, ABUSHAKRA, S, HERNANDEZ, C

Volltext

Prognostic utility of a semiquantitative spinal deformity index von Crans, Gerald G., Genant, Harry K., Krege, John H.

Volltext

Structural effects of raloxifene on the proximal femur : results from the multiple outcomes of raloxifene evaluation trial von UUSI-RASI, K, BECK, T. J, SEMANICK, L. M, DAPHTARY, M. M, CRANS, G. G, DESAIAH, D, HARPER, K. D

Volltext

Evaluation of vertebral fracture assessment by dual X-ray absorptiometry in a multicenter setting von Fuerst, T, Wu, C, Genant, H. K, von Ingersleben, G, Chen, Y, Johnston, C, Econs, M. J, Binkley, N, Vokes, T. J, Crans, G, Mitlak, B. H

Volltext

Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover von Delmas, P.D., Licata, A.A., Reginster, J.Y., Crans, G.G., Chen, P., Misurski, D.A., Wagman, R.B., Mitlak, B.H.

Volltext

Sustained viral response following treatment with direct acting antiviral agents for chronic hepatitis C and the risk of hepatocellular carcinoma von Reddy, K.R, Bourliere, M, Agarwal, K, Lawitz, E, Osinusi, A, Kersey, K, Crans, G, Moody, S, Ni, L, Brainard, D.M, McHutchison, J.G, Muir, A.J, Buti, M

Volltext

Sofosbuvir-based all-oral regimens for patients with chronic hepatitis C genotype 2 infection: integrated analysis of eleven clinical studies von Zeuzem, S, Han, K.-H, Ahn, S.-H, Lim, Y.-S, Kao, J.-H, Chuang, W.-L, Omata, M, Abramov, F, Crans, G, Llewellyn, J, Natha, M, De-Oertel, S, Brainard, D, Foster, G.R, Gane, E.J, Lawitz, E, Ho, S.B, Jacobson, I.M

Volltext

Reduction in vertebral fracture risk in teriparatide-treated postmenopausal women as assessed by spinal deformity index von Genant, Harry K., Siris, Ethel, Crans, Gerald G., Desaiah, Durisala, Krege, John H.

Volltext

Anti-vertebral fracture efficacy of raloxifene : a meta-analysis von SEEMAN, Ego, CRANS, Gerald G, DIEZ-PEREZ, Adolfo, PINETTE, Karen V, DELMAS, Pierre D

Volltext

Efficacy and Safety of Raloxifene 60 Milligrams/Day in Postmenopausal Asian Women von Kung, Annie W. C., Chao, Hsiang-Tai, Huang, Ko-En, Need, Allan G., Taechakraichana, Nimit, Loh, Foo-Hoe, Gonzaga, Florante, Sriram, Usha, Ismail, Nik Mohd Nasri, Farooqi, Abid, Rachman, Ichramsjah Azim, Crans, Gerald G., Wong, Mayme, Thiebaud, Daniel

Volltext

Differential Effects of Teriparatide on BMD After Treatment With Raloxifene or Alendronate von Ettinger, Bruce, Martin, San Javier, Crans, Gerald, Pavo, Imre

Volltext

Anti-vertebral fracture efficacy of raloxifene: a meta-analysis von Seeman, Ego, Crans, Gerald G, Diez-Perez, Adolfo, Pinette, Karen V, Delmas, Pierre D

Volltext

SAT-274 - Sofosbuvir-based all-oral regimens for patients with chronic hepatitis C genotype 2 infection: integrated analysis of eleven clinical studies von Zeuzem, S., Han, K.-H., Ahn, S.-H., Lim, Y.-S., Kao, J.-H., Chuang, W.-L., Omata, M., Abramov, F., Crans, G., Llewellyn, J., Natha, M., De-Oertel, S., Brainard, D., Foster, G.R., Gane, E.J., Lawitz, E., Ho, S.B., Jacobson, I.M.

Volltext

The Effects of ELND005 (Scyllo-Inositol) on Emergence of Neuropsychiatric Symptoms (NPS) in Mild/Moderate Alzheimer's Disease: Results from a 78-Week Phase 2 Study (P04.215) von Tariot, P., Lyketsos, C., Crans, G., Cedarbaum, J., Hernandez, C., Abushakra, S.

Volltext

Responder Analyses from a 78-Week Phase 2 Placebo-Controlled Study of ELND005 (Scyllo-Inositol) in Mild to Moderate (MM) Alzheimer's Disease (AD) (P04.195) von Salloway, S., Sperling, R., Porsteinsson, A., Crans, G., Hernandez, C., Abushakra, S.

Volltext

Responders to ELND005 (Scyllo-Inositol) Demonstrate Clinical and Biomarker Characteristics Consistent with Mild Alzheimer's Disease (AD): Data from a 78-Week Phase 2 Study in Mild... von Porsteinsson, A., Sperling, R., Salloway, S., Crans, G., Hernandez, C., Abushakra, S.

Volltext

Raloxifene prevents the growth of uterine leiomyomas in premenopausal women von Jirecek, Stefan, Lee, Andreas, Pavo, Imre, Crans, Gerald, Eppel, Wolfgang, Wenzl, Rene

Volltext

Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years von Jolly, Elaine E., Bjarnason, Nina H., Neven, Patrick, Plouffe, Leo, Johnston, C. Conrad, Watts, Steven D., Arnaud, Claude D., Mason, Timothy M., Crans, Gerald, Akers, Robin, Draper, Michael W.

Volltext

Association of severe vertebral fractures with reduced quality of life: Reduction in the incidence of severe vertebral fractures by teriparatide von Crans, G. G., Silverman, S. L., Genant, H. K., Glass, E. V., Krege, J. H.

Volltext